Cardipro Plus Tablet 50 mg+25 mg is a combination medication used for the treatment of high blood pressure (hypertension). Atenolol is a beta-blocker that reduces heart rate and blood pressure, while Chlorthalidone is a diuretic (water pill) that helps to eliminate excess fluid from the body. Together, they help lower blood pressure, reduce the risk of stroke, heart attack, and kidney problems.
The primary use of Cardipro Plus Tablet 50 mg+25 mg is in the management of hypertension (high blood pressure). It can also be used to reduce the risk of cardiovascular events in patients with hypertension. In some cases, this combination may be used to manage other cardiovascular conditions where both blood pressure and fluid retention need to be controlled.
| Brand Name | Cardipro Plus |
|---|---|
| Type | Tablet |
| Weight | 50 mg+25 mg |
| Generic | Atenolol + Chlorthalidone |
| Manufacturer | Square Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Atenolol works by blocking beta-adrenergic receptors in the heart, reducing the force and rate of the heart's contractions, which leads to a decrease in blood pressure. Chlorthalidone, on the other hand, acts on the kidneys to reduce sodium reabsorption, leading to increased excretion of water and electrolytes, which helps decrease blood pressure by reducing fluid volume in the bloodstream.
The antihypertensive effects of Cardipro Plus Tablet 50 mg+25 mg may be seen within a few hours of administration, but it may take up to 1 to 2 weeks for full blood pressure control to be achieved. Regular use is important for maintaining consistent blood pressure levels.
Atenolol is well absorbed from the gastrointestinal tract, with an oral bioavailability of about 50%. Chlorthalidone is also well absorbed, with peak plasma levels occurring within 2 to 6 hours after oral administration. Food does not significantly affect the absorption of either drug.
Atenolol is primarily excreted unchanged in the urine, while Chlorthalidone is mainly excreted unchanged via the kidneys. Both drugs rely on renal function for clearance.
The typical dosage of Cardipro Plus Tablet 50 mg+25 mg is one tablet daily. Dosage strength varies, but common combinations include:
Cardipro Plus Tablet 50 mg+25 mg should be taken orally, preferably at the same time each day. It can be taken with or without food. The tablet should be swallowed whole with a glass of water. If a dose is missed, it should be taken as soon as remembered, unless it is close to the time of the next dose.
Common side effects include:
Overdose of Cardipro Plus Tablet 50 mg+25 mg can lead to severe bradycardia, hypotension, electrolyte disturbances, and dehydration. In severe cases, overdose may result in heart failure or renal failure. Immediate medical intervention is required in cases of overdose, including supportive care and, if necessary, the administration of intravenous fluids and electrolytes.
Cardipro Plus Tablet 50 mg+25 mg should be used with caution in patients with renal impairment, as both drugs are eliminated through the kidneys. Patients with diabetes should also be monitored closely, as beta-blockers may mask symptoms of hypoglycemia. Caution is also advised in patients with respiratory disorders, such as asthma, due to Atenolol's potential to cause bronchoconstriction.
Cardipro Plus Tablet 50 mg+25 mg can interact with:
Use with caution in patients with:
Important drug interactions include:
Food does not significantly affect the absorption of Atenolol or Chlorthalidone. However, patients should maintain adequate fluid intake to prevent dehydration, especially when on a diuretic.
Atenolol is classified as pregnancy category D due to evidence of fetal harm in humans. It should only be used during pregnancy if the potential benefits outweigh the risks. Chlorthalidone is also not recommended during pregnancy as it may cause electrolyte disturbances in the mother and fetus.
Atenolol is excreted in breast milk and may affect a nursing infant, leading to bradycardia or other cardiovascular effects. Chlorthalidone may also be excreted in breast milk. Breastfeeding is generally not recommended during treatment with Cardipro Plus Tablet 50 mg+25 mg.
In the event of an acute overdose, symptoms may include severe hypotension, bradycardia, electrolyte imbalances, and dehydration. Immediate medical attention is required, including supportive care, intravenous fluids, electrolyte replacement, and monitoring of cardiovascular and renal function.
Cardipro Plus Tablet 50 mg+25 mg is contraindicated in patients with:
Cardipro Plus Tablet 50 mg+25 mg should be taken orally, typically once daily. The medication should be taken at the same time each day, and patients should follow their doctor’s directions for dose adjustments based on blood pressure response. It can be taken with or without food.
Store Cardipro Plus Tablet 50 mg+25 mg tablets at room temperature (20-25°C), away from moisture, heat, and direct sunlight. Keep the medication out of reach of children.
The volume of distribution for Atenolol is approximately 50-75 L, indicating it has limited tissue penetration. Chlorthalidone has a volume of distribution of around 3-8 L/kg, indicating extensive tissue binding, particularly in red blood cells.
Atenolol has a half-life of approximately 6 to 7 hours, while Chlorthalidone has a much longer half-life, ranging from 40 to 60 hours, allowing for once-daily dosing.
Atenolol is primarily cleared through renal excretion, with about 85% of an oral dose excreted unchanged in the urine. Chlorthalidone is also excreted primarily via the kidneys, with a clearance rate that may be prolonged in patients with renal impairment.
See in details version Cardipro Plus Tablet 50 mg+25 mg also Cardipro Plus Tablet 50 mg+25 mg in bangla